INTRODUCTION
Noroviruses (NoVs) are considered as the leading cause of diarrheal diseases in all groups of age; it is estimated that NoVs cause 50% of all worldwide outbreaks of viral gastroenteritis [Patel et al., 2008] . The infection may be occurring through contaminated water or food and person-to-person contacts [Hedberg and Osterholm, 1993; Koopmans et al., 2002; Marshall and Bruggink, 2011] .
Genetically diverse, NoVs are classified into five distinct genogroups (G) and further subdivided into genotypes. Genogroup I (GI) and genogroup II (GII) are recognized as the predominant cause of outbreaks in humans. The NoV genome, a positive sense singlestranded RNA, is organized into three open-reading frames (ORFs). ORF1 encodes for the non-structural proteins including a RNA-dependent RNA polymerase (RdRp) . The viral capsid protein (VP1) is encoded by ORF2 gene and regulates the virus antigenicity, hostspecificity, and environmental stability [Siebenga et al., 2010] ; the minor structural protein is encoded by ORF3 with unknown function [Belliot et al., 2003 ]. In the last decade the number of reports about NoV outbreaks increased worldwide. Data published by the systems of NoV surveillance (NoroNet; CaliciNet; ViroNet) describe the GII.4 strain as the genotype predominant in human circulating in the world and new GII.4 genetic variants were identified associated with epidemic events [Bull et al., 2006; Tu et al., 2008; Siebenga et al., 2009; Eden et al., 2010] . The literature does not report data about NoV outbreaks in Albania. A large circulation of enteric viruses has been reported in this country during 2002-2003 by Arrivi et al. [2007] with 12.9% of NoVs presence among recognized viral gastroenteritis (11 cases have been GII strains related). The first described outbreak of NoV occurred in Ballsh district during the spring 2010 [Donia et al., 2011] ; the RT-PCR identified a single NoV strain genotyped as GII.4. The aims of this study were: a molecular characterization of the NoV GII strains detected in Albania during two different time periods (the strains identified during the outbreak occurred in 2010 and the strains identified from sporadic cases of diarrhoea during [2002] [2003] and the comparison of these, by phylogenetic analysis, with the GII strains and GII.4 sub-genotypes circulating in the European epidemiological scenery, at the time of detection, basing on the data recorded in the main Surveillance Networks for NoV.
MATERIALS AND METHODS

Specimen Collection
Stool samples were collected from patients with gastroenteritis [Arrivi et al., 2007] admitted to the Pediatric ward and to the Emergency pediatric Unit of the Tirane University Hospital, during 2002 Hospital, during -2003 and from the Ballsh outbreak, which occurred in 2010 as reported previously [Donia et al., 2011] . All the samples were transferred to Tor Vergata University (Rome, Italy) employing the cold chain requirement and stored immediately at À808C. Screening for NoV presence was performed by ELISA in the hospital in Albania and by RT-PCR method in Italy.
RNA Extraction
Viral RNA was extracted using Trizol LS reagent (Invitrogen, Life Technology, Italy), according to the manufacturer's instructions, from faecal specimens prepared as described previously [Donia et al., 2011] .
RT-PCR Amplification
Several portions of ORF1 and ORF2 regions of the NoV genome were amplified by RT-PCR. In 2002 , the detection of NoV from stool samples was obtained using the method proposed by Hä fliger et al. [1997] which amplifies a part of ORF1 genome (region A). Subsequently an additional test was carried out from positive stool samples for NoV GII, stored at À808C, using the protocol applied for the diagnosis of the Ballsh outbreak [Donia et al., 2011] . RNA was reverse transcribed to complementary DNA (cDNA) with 50 pmol of random hexamers (Roche, Milan, Italy) in 20 ml of the reaction mixture containing 4 U of AMV (avian myeloblastosis virus) reverse transcriptase (Promega, Milan, Italy) . After incubation at 428C for 1 hr, 5 ml of cDNA were amplified in a semi-nested PCR targeting a 344 bp size of the ORF1/ORF2 genome (region C). The first round of PCR was carried out using COG2F and G2SKR primers, the second round of PCR using primers G2SKF and G2SKR Kageyama et al., 2003] . The region D of VP1 gene was amplified in a single round of PCR according to Vinjé et al. [2004] . In addition, all cDNAs (from samples collected during 2002-2003 and 2010) were tested by a semi-nested PCR amplifying a 250 bp size of the ORF1 gene (region A) using a primers set designed previously in house and tested in a qRT-PCR applied in environmental analyses (data not 
Sequence Analysis of Amplification Products
The amplified products were visualized under UV lamp after electrophoresis in 2% agarose gel stained with ethidium bromide. The positive fragments were purified using the Qiaquick kit (Qiagen, Milan, Italy), according to the manufacturer's instructions, and sequenced by the Big Dye Terminator Cycle Sequencing Ready Reaction version 2.0 (Perkin-Elmer, Rome, Italy). Forward primers were used to sequencing amplicons of ORF1 and ORF2 regions and the reverse primer to sequencing amplicons of the region D (VP1 gene). Genotyping was determined using the tool of NoV genotyping at http://www.rivm.nl web site (National Institute of Public Health and the Environment, the Netherlands); whereas, the most closely related homology of the sequences has been established by BLAST search program (http://www.ncbi.nlm. NCBI.gov/BLAST). Reference strains for phylogenetic analysis were selected from the RIVM and NCBI. Multiple sequences were aligned with reference strains using MULTALIN software [Corpet, 1988] , after manual adjustment of the sequences, and phylogenetic analyses were conducted using MEGA version 5.05 [Tamura et al., 2011] . Phylogenetic trees were constructed by the neighbor-joining method and the reliability was determined by bootstrap re-sampling of 1,000 replicates. Only nodes with a bootstrap value >60% are labeled.
Nucleotide Sequence Accession Numbers
The nucleotide sequences of NoV strains analyzed in this study were deposited in GenBank under accession numbers JQ861246-JQ861250.
RESULTS
A total of 21 Nov GII strains were examined for molecular analysis: 11 detected from patients with gastroenteritis collected during 2002-2003 and 10 from the outbreak occurred in Ballsh during the spring 2010. Overall, 42 sequences were obtained from the different regions amplified and the strains identified are listed in Table I .
Characterization of the NoV GII Strains Detected in 2002-2003
The NoV GII positive strains identified from patients of sporadic gastroenteritis (2002) (2003) were analyzed by sequencing. Eleven new sequences were obtained in addition to the previous results (11 sequences with SRII-2 primer) after the amplification tests carried out with the RT-PCR protocols targeting the regions mentioned above. In particular, three sequences for ORF1 (IIF primer), four sequences for ORF2 (G2SKF primer), and four sequences for VP1-region D (Cap C primer) were obtained. The genotyping of NoVs, obtained using NCBI data bank (SRII.2 primer), has classified four strains as GII.4, one strain as GII.2 while six strains have been assigned at GII genogroup but not genotyped clearly (Table I) . Subsequently, the RIVM website has confirmed one strain genotyped as GII.2, five strains genotyped as GII.4, three as GII.n and one strain as GII.b (Table I) . Using IIF/IIR/IIR2 primers, a proper amplicon has been obtained in 3 out of 11 positive stool samples that were clustered with Bristol/Lordsdale genotype (Fig. 1B) . The genetic analysis of ORF2 (regions C and D) was carried out from eight GII positive specimens because, in three cases, it was not possible to perform the amplification for lack of sample. The genotyping has identified GII.3 and GII.4 strains, in both capsid regions, for the samples 229/2003 229/ and 309/ 2003 229/ , respectively. Samples 11/2002 229/ and 14/2002 have shown a genotype non-concordant in capsid regions and they were identified between GII.3 and/or GII.2 genotype (Table I) .
Characterization of the Outbreak in Ballsh
During the outbreak event, NoV was detected by amplification of 344 bp size of the ORF1/ORF2 genome (region C) Kageyama et al., 2003] . Based on the NCBI data bank, all of the NoV GII strains detected were genotyped as GII.4 with a sequence homology of 98% with New Orleans-2009 strain (accession number: GU445325) [Donia et al., 2011] . Only one isolate (26/Ballsh) showed 99% homology with the New Orleans-2010 variant strain (accession number: JN595867; Table I ). According to the RIVM website, the 4/Ballsh isolate was assigned clearly to the GII.4 variant 2010 while the other GII.4 strains were classified as GU445325 strain, representing the variant New Orleans 2009 (Table I ). The amplification of 250 bp size of ORF-1gene (region A) carried out using IIF/IIR/IIR2 primers has produced a specific amplicon in 7 out of 10 positive samples. The homology analysis of the sequences has confirmed the GII.4 genotype but the strains of the outbreak were divided into two clusters (Fig. 1B) , three strains belonged to the Lordsdale cluster (NCBI) and four strains belonged to the GII.4 european variant 2010 (98% homology-Pecs/2010, accession number: HM625866). Equally, the RIVM genotyping tool has identified all strains belonging to the two clusters: Bristol/X76716 and the GII.4 variant 2010 (OB2009166 strain). In order to highlight genetic differences in VP1 (region D) among GII.4 isolates, as found in ORF-1 (region A) amplicons, four positive samples representative of the two ORF1 clusters were chosen and amplified in VP1 gene according to the protocol of Vinjé et al. [2004] . Three samples have produced a proper amplicon for subsequent sequencing. Based on the BLAST program, all of the three strains have been assigned to the GII.4 Russian variant 2010 (97% homology-accession number: HM596589). By RIVM website the GII.4 variant 2010 was confirmed clearly in one case (26/Ballsh), the other two GII.4 strains were classified as GU445325 genotype (Table I) . ; (D) ORF2, region D-Cap C primer [Vinjé et al., 2004] .
¼ number sample/year/primer. Trees were constructed by using the neighbor-joining method and evaluated by using the interior branch test method with Mega 5.05 software (www.megasoftware. net). Percentage of bootstrap support is shown by values at the branch nodes of the trees. Only nodes with a bootstrap value >60% are labeled; these values are the result of re-sampling the data 1,000 times.
A (ORF1), regions C and D (ORF2). In a first time the strains were classified by sequencing a tract of region A using SRII-2 primer. In a second time NoV GII strains were re-amplified and sequenced using IIF primer (region A), G2SKF primer (region C) and Cap C primer (region D). Unfortunately, not all faecal samples have produced a proper amplicon after the new rounds of the amplification. The IIF/IIR/IIR2 primers have shown a low sensitivity (three out of eleven positive GII strains) that was clustered to the Brostol/Lordsdale genotype (Fig. 1C) . Similar results were obtained by amplifying and sequencing the regions of capsid genome. (Fig. 1B,D) . Indeed, analyzing data obtained on the basis of the sequencing of the region A, the strain 11/2002 was confirmed as recombinant strain (GII.h, accession number: AB089882) while the strain 14/2002 showed high homology with other NoV GII strain as reported by Ambert-Balay et al. [2005] . The same classification was observed for the strains 96/2002 and 106/2002 after the analysis of ORF1 sequences; for these strains it can be hypothesized the recombination event because not supported from the sequencing of the capsid regions (Table I ). The strain 229/2003 showed a sequence homology in ORF1 related closely to GII.b recombinant strain (accession number: AY 682549), in ORF2 the homology was closely related to GII.3 strain as identified in France in August 2000 [Ambert-Balay et al., 2005] . Five strains were classified as NoV GII.4 (Table I) (Fig. 1A) . Unfortunately, we have not information about any outbreaks relatively to the time period analyzed.
Genotyping of the outbreak strains was completed amplifying a portion of the three regions of the genome. The common origin of the outbreak was defined because of all the isolates were found to belong to GII.4 genotype (Fig. 1C) . However, slight variations were observed comparing the sequence homology of the region A among data banks. GII.4 sub-type variant 2010 was straightaway assigned to 4/Ballsh by RIVM and to 26/Ballsh by BLAST websites. The primers used to amplify this region (IIF/IIR/IIR2) revealed a good sensitivity and specificity in detection and genotyping (70%) but a little less effectiveness in sub-typing (57% of sequences were assigned to a GII.4 variant). Indeed, the phylogenetic analysis has divided the strains in two clusters for few amino acid differences (Fig. 1B) . In particular, substitutions were observed in the amplicon at the position 2, M > V, position 8, K > T, position 48, I > T (in four strains) respect to the Lordsdale cluster; two other substitution were observed in all of the strains at position 69, N > K, position 71, N > D, respect to the GII.4 New Orleans variant 2010. Many amino acid substitutions have been identified in the central region of RdRp, as reported in the literature . This primers have demonstrated to produce a specific amplicon after a single round of PCR (70%) reducing the detection times (data not shown). This last result disagrees with Kojima et al. [2002] that report a lower detection capability of primers to target the central region of RdRp, after the first step of PCR (31%), in a broader range of NoV GII strains. The sequence analysis of VP1 region D of the genome has been obtained from three samples. The outbreak strain was assigned, by sequence homology analysis, to the GII.4 variant 2010, considered the pandemic variant responsible of the epidemic events that occurred worldwide during 2009-2010 [Mathijs et al., 2011; Vega et al., 2011] . Over the last decade five NoV pandemic events have been reported associated with the genotype GII.4 and each of them have been trigged from a mutated strain [Blanton et al., 2006; Bull et al., 2006; Tu et al., 2008; Siebenga et al., 2009] . In the absence of a reliable cell culture system, the RT-PCR is considered the gold standard for NoV detection. A large selection of primers are available currently and these are able to amplify the most of genetic variants arising from the accumulation of point mutations associated with genetic recombination events. Most of the investigators have chosen primers for conserved regions, such the RdRp gene, in order to detect the greatest number of different strains [Jiang et al., 1990 [Jiang et al., , 1993 Ando et al., 2000; Katayama et al., 2002; Vinjé et al., 2004] but not all sequences can be accurately classified into the proper clusters by phylogenetic analyses [Zheng et al., 2006] ; however, GII.4 variants were observed after the molecular analysis of the ORF1 region [Marshall and Bruggink, 2011] . During the last years it highlights a lack of reported data about sequence analyses of RdRp region that could suggest the use of this approach in addition to the VP1 capsid protein study chosen by the major networks of NoV surveillance [Park et al., 2011] .
The recombination events in the NoV have been demonstrated as a common feature reported likely in other RNA virus . During 2006, the NoV GIIb/GII.3 recombinant was the most prevalent NoV strain involved in outbreaks and investigated in Queensland, Australia . A similar recombinant strain was identified in France since 2000 as reported by Ambert-Balay et al. [2005] . In this study, six NoV GII strains have been characterized as GII recombinant strains, all of them among those detected during 2002-2003. The molecular characterization is an important tool to better understand the genetic variability of NoVs. The New Orleans GII.4 variant was first identified in October 2009 causing 60% of the outbreaks worldwide, replacing the predominant GII.4 Minerva strain. As expected, the rapid global spread of emerging GII.4 variants during the last 10 years has involved also the Albania. Data reported in this study reflect the contemporary presence in Albania of NoVs strains circulating in Europe during the years considered.
